Solid Biosciences Inc. (SLDB) Social Stream
SOLID BIOSCIENCES INC (SLDB) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SLDB.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 6 | $17 | $5.5 | $10.3 | $2.75 | 274.55% |
| 2022-03-14 | 5 | $17 | $5.5 | $10.3 | $2.75 | 274.55% |
| 2022-03-15 | 4 | $17 | $5 | $10.2 | $2.75 | 270.91% |
| 2022-04-28 | 5 | $12 | $5 | $7.4 | $2.75 | 169.09% |
| 2022-05-18 | 4 | $12 | $2 | $6.5 | $2.75 | 136.36% |
| 2022-08-11 | 5 | $12 | $2 | $6.5 | $2.75 | 136.36% |
| 2022-08-15 | 5 | $12 | $2 | $6.25 | $2.75 | 127.27% |
| 2022-10-03 | 5 | $12 | $1 | $6 | $2.75 | 118.18% |
| 2022-10-18 | 5 | $6 | $1 | $3.25 | $2.75 | 18.18% |
| 2022-11-11 | 6 | $89.955 | $6 | $37.383 | $2.75 | 1259.38% |
| 2023-01-13 | 6 | $89.955 | $6 | $32.152 | $2.75 | 1069.16% |
| 2023-05-12 | 6 | $89.955 | $6 | $23.591 | $2.75 | 757.85% |
| 2023-06-23 | 5 | $89.955 | $6 | $23.791 | $2.75 | 765.13% |
| 2023-08-16 | 4 | $8 | $6 | $7.25 | $2.75 | 163.64% |
| 2023-09-10 | 5 | $8 | $6 | $7 | $2.75 | 154.55% |
The Trend in the Analyst Price Target
Over the past 40 months, SLDB's average price target has gone up $2.83.
Over the past 49 weeks, SLDB's average upside potential has been 811.97%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-18 | 5 | 89.955 | 14.992 | 48.725 | 0.47 | 10267.02% |
| 2022-11-11 | 6 | 89.955 | 6.000 | 37.383 | 6.61 | 465.55% |
| 2022-11-18 | 6 | 89.955 | 6.000 | 32.152 | 6.86 | 368.69% |
| 2023-03-27 | 6 | 89.955 | 6.000 | 23.591 | 3.88 | 508.02% |
| 2023-09-10 | 5 | 8.000 | 6.000 | 7.000 | 3.21 | 118.07% |
SLDB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.2 | 2 | 0 | 3 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
SLDB's average broker recommendation rating improved by 0.3 over the prior 26 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- SLDB has a lower variance in analysts' estimates than -1821.54% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, SOLID BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 1956.99% of them.
- In terms of how SOLID BIOSCIENCES INC fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 792.74% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, SOLID BIOSCIENCES INC's number of analysts covering the stock is higher than 635.84% of them.
Stocks similar to SOLID BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are XFOR, APTO, and OTLK.
View All Top Stocks by Price Target
What is the outlook for SLDB? Use POWR Ratings for clearer insight into price direction.